R DerSimonian

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Resolving discrepancies between a meta-analysis and a subsequent large controlled trial
    R DerSimonian
    Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Development, Bethesda, MD 20892 7510, USA
    JAMA 282:664-70. 1999
  2. ncbi request reprint Random-effects model for meta-analysis of clinical trials: an update
    Rebecca DerSimonian
    Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    Contemp Clin Trials 28:105-14. 2007
  3. ncbi request reprint Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion
    M A Klebanoff
    Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    N Engl J Med 341:1639-44. 1999
  4. ncbi request reprint Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
    Kara B Anthony
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases NIH, 10 Center Drive, Building 10, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 33:125-33. 2003
  5. ncbi request reprint CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Infect Dis 196:677-83. 2007

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Resolving discrepancies between a meta-analysis and a subsequent large controlled trial
    R DerSimonian
    Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Development, Bethesda, MD 20892 7510, USA
    JAMA 282:664-70. 1999
    ....
  2. ncbi request reprint Random-effects model for meta-analysis of clinical trials: an update
    Rebecca DerSimonian
    Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    Contemp Clin Trials 28:105-14. 2007
    ..The two-step methods approximate the optimal iterative method better than the earlier one-step non-iterative methods...
  3. ncbi request reprint Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion
    M A Klebanoff
    Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    N Engl J Med 341:1639-44. 1999
    ..Prior studies have determined caffeine consumption by questionnaire. We used a biologic marker, such as serum paraxanthine, a metabolite of caffeine, to measure the dose of caffeine...
  4. ncbi request reprint Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
    Kara B Anthony
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases NIH, 10 Center Drive, Building 10, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 33:125-33. 2003
    ..These data suggest that immune activation is central to CD4 cell depletion in HIV infection and immune reconstitution with HAART...
  5. ncbi request reprint CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Infect Dis 196:677-83. 2007
    ..Intermittent interleukin (IL)-2 administration to human immunodeficiency virus (HIV)-infected patients leads to CD4(+) T cell expansions. The factors potentially affecting these expansions were investigated in the present study...